Navigation Links
UC Davis launches 'One Health' care for wild mountain gorillas and human neighbors
Date:4/23/2009

The University of California, Davis, today launched a new "One Health" program to conserve the world's remaining 740 mountain gorillas by caring for not only the gorillas but also the people and the other animals that share their home in the forests of central Africa.

With $750,000 in funding from the David and Lucile Packard Foundation, UC Davis will establish the Mountain Gorilla One Health Program in the School of Veterinary Medicine's Wildlife Health Center.

The new program will partner with the existing Mountain Gorilla Veterinary Project, begun in 1986, to continue improving gorilla health and survival by addressing human health, livestock health and agricultural issues.

"The concept of 'One Health' - that human, animal and environmental health are inextricably linked and should be considered holistically - is a core principle of the UC Davis Wildlife Health Center," said wildlife veterinarian and center assistant director Kirsten Gilardi, who will lead the Mountain Gorilla One Health Program.

"We are proud to become partners with the Mountain Gorilla Veterinary Project, one of the few true, on-the-ground examples of One Health in action anywhere in the world."

The Mountain Gorilla Veterinary Project's longtime director, veterinarian Michael Cranfield, will join the UC Davis staff while continuing to oversee the work of the project's seven veterinarians and 12 technicians and staff members in Rwanda, Uganda and the Democratic Republic of the Congo.

"The collaboration with UC Davis will help improve the health and welfare of the humans and animals living around the gorillas," Cranfield said. "This in turn acts as a buffer to help prevent disease - the gorillas' leading cause of death - from entering the park and affecting gorilla families."

UC Davis will investigate disease threats facing mountain gorillas, help expand medical care for the humans working in and around
'/>"/>

Contact: Sylvia Wright
swright@ucdavis.edu
530-752-7704
University of California - Davis
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. UC Davis researchers identify a protein that may help breast cancer spread, beat cancer drugs
2. UC Davis bench-to-bedside research: Promising treatment in clinical trials
3. UC Davis research shows that newly discovered drug reduces heart enlargement
4. UC Davis researchers find molecule that targets brain tumors
5. UC Davis discovery offers hope for treating kidney cancer
6. UC Davis team refines cancer treatments to reduce potential nerve damage
7. UC Davis researchers exploring gene therapy to fight AIDS
8. UC Davis researchers discover Achilles heel in pancreatic cancer
9. UC Davis researchers discover a key to aggressive breast cancer
10. UC Davis chemical ecologist wins major award
11. UC Davis researchers discover new drug target for inflammatory disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014  23andMe, Inc., the leading personal genetics company, ... fine-scale differences in genetic ancestry of individuals from across ... Since immigrants first arrived more than four hundred years ... served as a meeting place for peoples from different ... ongoing mixing of peoples with African, European, and American ...
(Date:12/17/2014)... 15, 2014 Research and Markets ... the "Samsung Galaxy S5 - Home Button ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... sensing technology than the iPhone 5S, Samsung introduces ... its product. The Galaxy S5 home ...
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014 /PRNewswire-USNewswire/ ... a Good Clinical Practices (GCP) audit to confirm ... Administration (FDA) regulations. This accomplishment enables HITLAB to ... trials utilizing the highest principles for patient safety ... to improve global healthcare access, quality, and delivery ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... If grandma seems to forget things, will she end up ... few symptoms that may signal which 70-year-olds risk developing dementia. ... Academy at the University of Gothenburg, Sweden. Several of ... developing dementia do not seem to work any longer. The ...
... in Spanish . , DNA-Prokids ( http://www.dna-prokids.org ... using genetic identification of victims and their relatives, was officially ... (UGR) headquarters, in Spain. Traffic in human beings is ... beginning of the 21st century. According to data from the ...
... Iowa -- Researchers at Iowa State University have discovered ... plant growth. , Yanhai Yin, an assistant professor in ... a plant hormone called brassinosteroids. The hormone controls the ... major impact on how large the plant grows, says ...
Cached Biology News:Early identification of dementia increasingly difficult 2DNA-Prokids: Genetic identification against traffic in human beings 2ISU researcher identifies genetic pathway responsible for much of plant growth 2
(Date:12/24/2014)... Long Island, New York (PRWEB) December 23, 2014 ... , and the Long Island Affiliate of ITRA Global, the ... economy’s slow but steady recovery. This is evidenced by ... and the strong stock market. Low energy costs have ... low. The only negative is the housing market remaining ...
(Date:12/24/2014)... The report expects global cell isolation ... It also provides a carefully analyzed data about the ... the market. , Full Copy of Report @ ... market for cell expansion will keep witnessing growth at ... growth to be driven by rapid technological advancements, government ...
(Date:12/24/2014)... 23, 2014 Vermillion, Inc. (Nasdaq:   ... disease, announced today that investors including Oracle Investment ... LLC and several Vermillion directors have agreed to ... Vermillion,s common stock and warrants to purchase unregistered ... placement.  Under the terms of ...
(Date:12/24/2014)... SARASOTA, Fla. , Dec. 23, 2014  Rock ... today that it has filed a Clinical Trial Application ... Medicines Healthcare products Regulatory Agency (MHRA) seeking regulatory approval ... its lead molecule, Anatabine Citrate. Contingent on ... to conduct a Phase I trial to assess the ...
Breaking Biology Technology:ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... WOODLANDS, Texas, Oct. 4 Lexicon,Pharmaceuticals, Inc. (Nasdaq: ... Lexicon,s president and chief executive officer, will present,at the ... California,on Thursday, October 11, 2007 at 11:00 a.m. Pacific ... be accessed on its,corporate website at http://www.lexpharma.com . ...
... In conjunction with,its third quarter 2007 earnings release (expected ... (NYSE: CVD ) is pleased to invite you to,listen ... over the Internet on Thursday, October 25 at 9:00 a.m. ... Webcast and Slide Presentation When: October 25, ...
... VRUS ) has entered into a working capital loan ... and conditions of,the agreement, Horizon will advance $10 million ... may receive a second loan of $10 million,by March ... by November 30, 2008,provided conditions precedent to making the ...
Cached Biology Technology:Lexicon Pharmaceuticals to Present at Bio InvestorForum 2Pharmasset Accesses up to $30 Million of Working Capital 2Pharmasset Accesses up to $30 Million of Working Capital 3
...
Sheep polyclonal to Quinolone ( Abpromise for all tested applications). Antigen: Norfloxacin(N)conjugated to BSA...
Certified U.S. origin. Bovine Serum:, *Certified U.S. origin. Available raw, nonsterile filtered, or sterile filtered. , , *Sterility tested , , *Low Hemoglobin levels , , *Mycoplasma testing upon...
...
Biology Products: